Andreas Seidl
Chief Tech/Sci/R&D Officer bei FORMYCON AG
Profil
Andreas Seidl is currently the Chief Operating Officer at LEUKOCARE AG and the Chief Scientific Officer at Formycon AG.
He holds a doctorate degree from Universität Konstanz.
Aktive Positionen von Andreas Seidl
| Unternehmen | Position | Beginn |
|---|---|---|
| FORMYCON AG | Chief Tech/Sci/R&D Officer | 01.07.2022 |
LEUKOCARE AG
 LEUKOCARE AG Medical/Nursing ServicesHealth Services LeukoCare AG develops protein stabilization and protection solutions. The firm specializes in the development of protein stabilization and protection solutions for biopharmaceuticals, vaccines, medical devices, and diagnostics technologies. Its service areas encompass technology licensing, prototyping and product development, clinical registration, biological and chemical testing, and consulting. The company was founded by Martin Scholz in 2001 and is headquartered in Munich, Germany. | Chief Operating Officer | 01.04.2019 |
Ausbildung von Andreas Seidl
| Universität Konstanz | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| FORMYCON AG | Health Technology |
| Private Unternehmen | 1 |
|---|---|
LEUKOCARE AG
LEUKOCARE AG Medical/Nursing ServicesHealth Services LeukoCare AG develops protein stabilization and protection solutions. The firm specializes in the development of protein stabilization and protection solutions for biopharmaceuticals, vaccines, medical devices, and diagnostics technologies. Its service areas encompass technology licensing, prototyping and product development, clinical registration, biological and chemical testing, and consulting. The company was founded by Martin Scholz in 2001 and is headquartered in Munich, Germany. | Health Services |
